The use of ACTH and corticosteroids in myasthenia gravis.
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007362:Intensive Care Units; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009132:Muscles / Q000187:drug effects; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009431:Neural Conduction / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D010913:Pituitary-Adrenal System / Q000187:drug effects; D013934:Thymectomy; D013950:Thymus Gland / Q000187:drug effects
D007166:Immunosuppressive Agents; D000324:Adrenocorticotropic Hormone